Goldman Sachs’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Sell |
395,008
-82,643
| -17% | -$4.21M | ﹤0.01% | 1770 |
|
|
2025
Q1 | $21.5M | Sell |
477,651
-77,985
| -14% | -$3.51M | ﹤0.01% | 1650 |
|
|
2024
Q4 | $23M | Sell |
555,636
-82,331
| -13% | -$3.4M | ﹤0.01% | 1678 |
|
|
2024
Q3 | $24.9M | Sell |
637,967
-121,051
| -16% | -$4.72M | ﹤0.01% | 1568 |
|
|
2024
Q2 | $26M | Buy |
759,018
+58,902
| +8% | +$2.01M | ﹤0.01% | 1412 |
|
|
2024
Q1 | $17.6M | Buy |
700,116
+243,798
| +53% | +$6.12M | ﹤0.01% | 1643 |
|
|
2023
Q4 | $13.5M | Buy |
456,318
+215,542
| +90% | +$6.36M | ﹤0.01% | 1850 |
|
|
2023
Q3 | $7.61M | Sell |
240,776
-34,120
| -12% | -$1.08M | ﹤0.01% | 2180 |
|
|
2023
Q2 | $7.11M | Sell |
274,896
-117,476
| -30% | -$3.04M | ﹤0.01% | 2312 |
|
|
2023
Q1 | $9.42M | Sell |
392,372
-49,403
| -11% | -$1.19M | ﹤0.01% | 2059 |
|
|
2022
Q4 | $8.61M | Buy |
441,775
+205,747
| +87% | +$4.01M | ﹤0.01% | 2234 |
|
|
2022
Q3 | $4.96M | Buy |
236,028
+114,220
| +94% | +$2.4M | ﹤0.01% | 2646 |
|
|
2022
Q2 | $2.37M | Buy |
121,808
+93,071
| +324% | +$1.81M | ﹤0.01% | 3309 |
|
|
2022
Q1 | $633K | Sell |
28,737
-12,536
| -30% | -$276K | ﹤0.01% | 4431 |
|
|
2021
Q4 | $658K | Buy |
+41,273
| New | +$658K | ﹤0.01% | 4341 |
|
|
2020
Q4 | – | Sell |
-22,919
| Closed | -$442K | – | 4710 |
|
|
2020
Q3 | $442K | Sell |
22,919
-8,021
| -26% | -$155K | ﹤0.01% | 3730 |
|
|
2020
Q2 | $602K | Sell |
30,940
-7,177
| -19% | -$140K | ﹤0.01% | 3500 |
|
|
2020
Q1 | $534K | Buy |
+38,117
| New | +$534K | ﹤0.01% | 3463 |
|
|
2019
Q4 | – | Sell |
-11,066
| Closed | -$111K | – | 4341 |
|
|
2019
Q3 | $111K | Buy |
+11,066
| New | +$111K | ﹤0.01% | 4035 |
|